News
Hosted on MSN18d
These 2 Buy-Rated Dividend Stocks Could Be Next in Line for a Trump Tariff Selloff. Should You Jump Ship Now?The U.S. remains heavily reliant on imported drugs from low-cost manufacturing hubs like ... Companies like Amgen (AMGN), benefiting from reduced tax rates due to operations in Ireland and Singapore, ...
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed ... employing around 7,000 employees, with Amgen, GSK, Pfizer, AbbVie, MSD, Novartis, and ...
Biopharmaceutical stocks are having their time in the spotlight thanks to President Donald Trump, who vowed to take aim at Ireland’s status as a pharma hub with new tariffs. Analysts at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results